A widely available antiviral medication offers new possibilities for long Covid patients seeking relief from debilitating ...

Symptoms mirror Omicron’s, that is, fever, cough, fatigue, sore throat, and muscle aches. Though India’s Covid response ...

A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to ...

A Wall Street maxim states, “Twenty percent of investors who want to make money are in stocks, while the other 80 percent who ...

Encounter-level factors played a key role in limiting outpatient COVID-19 treatment for Black and Latino patients.

Scientists are currently studying how well people are protected against severe disease from XFG. Researchers conducted lab ...

Pfizer has revealed what it will charge for a five-day course of its oral antiviral Paxlovid for COVID-19 when it starts to see it on the commercial market later this year. The drugmaker has set a ...

The most dominant COVID variant is LP.8.1, which at last count has made up 38% of cases, with Nimbus at 37%, variants XFG at ...

“Well, it’s not over,” Harkins told Source NM in an interview this week. “The pandemic is smoldering. There are still people that are getting sick. You can still get COVID. There’s still a significant ...